Former President Trump’s Presidential Federal Advisory Committee for COVID-19 needs to be reestablished under President Biden.
The United States Senate HELP Committee will hold a hearing tomorrow to officially begin the process of formulating legislation to strengthen our pandemic preparation and response. As a first step the committee will examine lessons learned from COVID-19. The committee took the unusual step of requesting written public comment and posting both an outline and working draft of the proposed legislation.
The legislative outline describes the formulation of a bipartisan Task Force to examine the emergence of SARS-CoV-2, and the United States’ Preparation
and Response to COVID-19. In addition, there are provisions regarding the functioning of the Centers for Disease Control and Prevention (CDC) and appointment of the CDC Director. There are provisions to improve local, state, and federal public health responses, along with addressing social disparities. Further provisions are designed to improve and modernize biosurveillance, data reporting, sharing and dissemination, and to accelerate research development of counter measures. The national strategic stockpile and supply chain are addressed. Finally, there are provisions to modernizing clinical trials and streamlining drug and vaccine development and review.
All of these provisions focus on acronyms of the CDC, FDA, BARDA, ASPR, NIAID and the GAO. What is missing is OSHA and frontline worker protection, this includes infection preventionists. This was the focus of the written public comment submitted by Health Watch USA (of which the author is the founder and president). A new Title (Title VI) was proposed which would address frontline worker safety:
This comment also called for augmenting the CDC’s authority to investigate outbreaks in consultation with local and state health departments. And to eliminate outside conflicts of interest created by non-governmental sources of CDC funding (i.e., CDC Foundation).
Previously on January 15, 2022, a letter was sent by Health Watch USA, the Massachusetts Nurses Association, and National Nurses United to the White House and faxed to Senator Mitch McConnell’s and Senator Chuck Schumer’s(9) offices, requesting that an independent Presidential Federal Advisory Committee for COVID-19 be reestablished under the Biden Administration.
The United States’ COVID-19 response is among the worst of highly developed nations. We can and need to do better. I feel the above will provide an outline for the U.S. to embark in a new direction and achieve optimal pandemic preparedness and response.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.